BioPorto A/S
THOXF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$73.77M
Close$
$-0.15
199.7% downside
Current Fair Value
199.7% downsideOvervalued by 199.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $73.77 Million |
|---|---|
| Enterprise Value | $4.26 Million |
| Earnings per Share | $-0.15 |
| Beta | 1.38 |
| Outstanding Shares | 495,109,000 |
Return
| Return on Equity | 10.41% |
|---|---|
| Return on Assets | 7.85% |
| Return on Invested Capital | 6.77% |
Valuation & Multiples
| P/E Ratio | 76.63 |
|---|---|
| PEG | -25.7 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.11 |
| Enterprise Value to EBIT | 0.74 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 1.36 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$1.13 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 19, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$1.45 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BioPorto A/S
44 employees
CEO: Carsten Buhl
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offe...